Clinical Trial Update: CVD 909 Vi Prime Boost Study [Phase 1]

View source ↗

Summary

The update notes the completion of Phase 1 testing for the CVD 909 Vi Prime Boost typhoid vaccine candidate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Typhoid Fever

Drugs mentioned

• CVD 909 Vi Prime Boost

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Typhoid Fever | Phase 1 | Status: COMPLETED